explore -WSS

explore

author：comprehensive 2025-10-02 19:21:03 - browse：87

Cathy McMorris Rodgers -- health policy coverage from STAT — Rep. Cathy McMorris Rodgers announced her plans to leave Congress at the end of 2024. Anna Moneymaker/Getty Images

WASHINGTON — Rep. Cathy McMorris Rodgers, the chair of a crucial House committee that handles health care issues, plans to leave Congress at the end of the year, she announced Thursday.

It will be a major shakeup for a panel already ravaged by Republican retirements. Reps. Michael Burgess (R-Texas), Larry Bucshon (R-Ind.), Jeff Duncan (R-S.C.), Debbie Lesko (R-Ariz.), Greg Pence (R-Ind.) and Kelly Armstrong (R-N.D.) are all leaving at the end of this Congress, too.

Under McMorris Rodgers, the panel led the way for House passage of a health care price transparency package that included the first major proposal to equalize payment between hospital outpatient departments and physician offices.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： FDA approves first treatment for ultra

explore

WSS

Patient advocates sound warning on FDA proposal on salt intake

NIH tests clinical research in primary care with $30 million program

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

Trump's false claims about Georgia's 2020 election long debunked

FDA approves first treatment for ultra

Eye stem cell transplant could help restore vision in injured people

entertainment

explore

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Report captures long Covid’s disabling effects and policy challenges

Affirmative action in medical school literally saved lives

Coercive sterilizations revealed by STAT prompt outrage

BioMarin wins approval for gene therapy to treat hemophilia A

Patient advocates sound warning on FDA proposal on salt intake

Hepatitis C has a cure — but many Americans still lack access to it

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Activists slam private health insurers over coverage restrictions

The pain doctors face in trying to build their families

focus

FDA approves first treatment for ultra

ActiGraph execs on goal of drug approvals with digital endpoints

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Liz Cheney makes 1st public comment since Trump's election interference indictments

Moderna says combo Covid

Patient advocates sound warning on FDA proposal on salt intake

entertainment

explore

entertainment

focus